Your browser doesn't support javascript.
loading
Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test.
Pu, Yiyi; Weng, Youhong; Wu, Yahan; Gao, Fei; Zheng, Xiaojun; Xiong, Xianqin; Lv, Hangjun; Kong, Qingming.
Affiliation
  • Pu Y; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
  • Weng Y; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Wu Y; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Gao F; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Zheng X; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Xiong X; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Lv H; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Kong Q; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
Front Cell Infect Microbiol ; 12: 915751, 2022.
Article in En | MEDLINE | ID: mdl-35719335

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Cell Infect Microbiol Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Cell Infect Microbiol Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza